← Open Payments lookup

KEVIN LAI: Open Payments

NPI 1992134258 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,834 in 77 payments from 20 companies in 2025. Trend: 2023 $1,459 · 2024 $1,668 · 2025 $1,834

Food & beverage: $1,642Education: $191
CompanyPaymentsAmount
Astellas Pharma US Inc8$335
TOLMAR, INC.13$260
Endo USA, Inc.9$213
Sumitomo Pharma America, Inc.11$197
Janssen Biotech, Inc.7$194
IMMUNITYBIO, INC.3$89
Dendreon Pharmaceuticals LLC4$74
Ferring Pharmaceuticals Inc.3$69
Bayer Healthcare Pharmaceuticals Inc.3$63
Antares Pharma, Inc.3$53

Products named: ERLEADA, XTANDI, XIAFLEX, ELIGARD, JATENZO, ORGOVYX, GEMTESA, ANKTIVA.

Industry payments across MA — which companies pay providers there.